Successful Isavuconazole Salvage Therapy for Cerebral Mucormycosis in A child With Relapsed Leukemia, A light in The Dark Tunnel
preprint
OA: closed
Abstract
Mucormycosis is an angioinvasive lethal fungal infection in pediatric cancer patients. We present 10-year-old female with relapsed B-cell acute lymphoblastic leukemia undergoing chemotherapy was diagnosed with isolated cerebral mucormycosis (ICM). Despite surgical debridement and liposomal amphotericin B, repeat imaging showed concern for disease progression. Chemotherapy was discontinued and the patient was discharged on salvage therapy oral isavuconazole (ISAV). Over two months later, the patient was unexpectedly clinically stable, and imaging showed near resolution. After confirming continuous disease remission, the patient was restarted on modified chemotherapy. Serial MRI’s during continued chemotherapy showed stable MRI findings. This case illustrates a rare presentation of successful salvage monotherapy ISAV for this deadly infection with complete remission for relapsed leukemia.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00